Logo Istituto Affiliato

Institute of Oncology Research (IOR),

affiliated to USI,

run by an


foundation with the same name


Publications - Experimental Therapeutics Lab


Relevant publications

  • Civenni G, Bosotti R, Timpanaro A, Vazquez R, Merulla J, Pandit S, Rossi S, Albino D, Allegrini S, Mitra A, Mapelli SN, Vierling L, Giurdanella M, Marchetti M, Paganoni A, Rinaldi A, Losa M, Mira-Cato E, D'Antuono R, Morone D, Rezai K, D'Ambrosio G, Ouafik L, Mackenzie S, Riveiro ME, Cvitkovic E, Carbone GM and Catapano CV. Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer. Cell Metab (2019) 30, 303-318 e306. https://www.ncbi.nlm.nih.gov/pubmed/31130467.
  • Mapelli SN, Napoli S, Pisignano G, Garcia-Escudero R, Carbone GM and Catapano CV. Deciphering the complexity of human non-coding promoter-proximal transcriptome. Bioinformatics (2019) 35, 2529-2534. https://www.ncbi.nlm.nih.gov/pubmed/30535182.
  • Civenni G, Albino D, Shinde D, Vazquez R, Merulla J, Kokanovic A, Mapelli SN, Carbone GM and Catapano CV. Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells. Front Oncol (2019) 9, 385. https://www.ncbi.nlm.nih.gov/pubmed/31143708.
  • Civenni G, Carbone GM and Catapano CV. Mitochondrial fission and stemness in prostate cancer. Aging (Albany NY) (2019) 11, 8036-8038. https://www.ncbi.nlm.nih.gov/pubmed/31575828.
  • Pisignano G, Napoli S, Magistri M, Mapelli SN, Pastori C, Di Marco S, Civenni G, Albino D, Enriquez C, Allegrini S, Mitra A, D'Ambrosio G, Mello-Grand M, Chiorino G, Garcia-Escudero R, Varani G, Carbone GM and Catapano CV. A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers. Nat Commun (2017) 8, 15622. https://www.ncbi.nlm.nih.gov/pubmed/28555645.
  • Genini D, Brambilla L, Laurini E, Merulla J, Civenni G, Pandit S, D'Antuono R, Perez L, Levy DE, Pricl S, Carbone GM and Catapano CV. Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells. Proc Natl Acad Sci U S A (2017) 114, E4924-E4933. https://www.ncbi.nlm.nih.gov/pubmed/28584133.
  • Roos M, Pradere U, Ngondo RP, Behera A, Allegrini S, Civenni G, Zagalak JA, Marchand JR, Menzi M, Towbin H, Scheuermann J, Neri D, Caflisch A, Catapano CV, Ciaudo C and Hall J. A Small-Molecule Inhibitor of Lin28. ACS Chem Biol (2016) 11, 2773-2781. https://www.ncbi.nlm.nih.gov/pubmed/27548809.
  • Civenni G, Malek A, Albino D, Garcia-Escudero R, Napoli S, Di Marco S, Pinton S, Sarti M, Carbone GM and Catapano CV. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer. Cancer Res (2013) 73, 6816-6827.

Collapse all